Navigation Links
MQ Associates, Inc. Announces Completion of Tender Offer and Consent Solicitation Relating to its 12 1/4% Senior Discount Notes due 2012
Date:1/31/2008

overnmental regulations that affect its ability to do business, actions of its competitors, introduction of new technologies, risks associated with its acquisition strategy and integration costs, and the additional factors and risks contained in MQ Associates' Annual Report on Form 10-K for the year ended December 31, 2006, as well as its other periodic reports filed with the SEC. MQ Associates undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as otherwise required by law.

MedQuest is a leading operator of independent, fixed-site, outpatient diagnostic imaging centers in the United States. MedQuest centers provide high quality diagnostic imaging services using a variety of technologies including magnetic resonance imaging (MRI), computed tomography (CT), nuclear medicine, general radiology, bone densitometry, ultrasound and mammography. MedQuest operates a network of 92 centers in 13 states located primarily throughout the southeastern and southwestern United States.


'/>"/>
SOURCE MQ Associates, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. MHA Announces: Managed Health Care Associates, Inc. (MHA) Expands Board of Directors
2. MQ Associates, Inc. Announces Cash Tender Offer for 121/4% Senior Discount Notes Due 2012 (CUSIP No. 55345RAC2) and Related Consent Solicitation
3. Shareholder Class Action Filed Against Health Management Associates, Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
4. MQ Associates, Inc. Announces Expiration of its Tender Offers for its 12 1/4% Senior Discount Notes Due 2012 (CUSIP No. 55345RAC2) and Medquest, Inc.s 11 7/8% Senior Subordinated Notes Due 2012 (CUSIP No. 58505DAD1)
5. National HealthCare Recognized for Outstanding Sales Leadership by Long Term Care Associates, Inc.
6. MQ Associates, Inc. Announces Results for the Third Quarter and Nine Months Ended September 30, 2007
7. Mount Sinai & ENT and Allergy Associates, LLP affiliate to fight cancer
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Hanger Orthopedic Group, Inc. Announces Senior Leadership Succession Plan and Reaffirms Guidance
10. Webcast Alert: HCA Announces 4Q-Year End 07 Earnings Report
11. Pennsylvania Governor Rendell Announces $1.8 Million Investment to Add Nurses, Improve Nurse Education Grants Awarded to Recipients in 28 Counties
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...HINGTON, July 25 /PRNewswire/ -- Klafter & Olsen L...Care Corporation ("ArthroCare" or the,"Company") (... U.S. District,Court for the Western District of T...hased the common stock ArthroCare from January 24,...chaser Class Period") and all,persons or entities ...
(Date:7/25/2008)...ASANTON, Calif., July 25 /PRNewswire-FirstCall/ --...der in device-based mechanical,circulatory support...arts,today announced that it will report its oper... months of fiscal 2008 on Thursday, July 31., The...s financial,results and operating activities to al...
(Date:7/25/2008)...ROOK, Ill. July 25, 2008 The American Society f...idelines on the role of endoscopy in the bariatric... in the United States and the success in surgical ...er of weight-loss surgeries performed in the U.S.,...lines discuss endoscopy in the preoperative patien...
(Date:7/25/2008)...ivanCotter Releases Results of Fourth Annual Physi...urvey, DETROIT, July 25 /PRNewswire/ -- Sullivan,...rth annual survey of physician on-call pay rates a...y Report. The survey report,with data from 132 he...ian,on-call pay practices and rates paid for 33 ph...
Breaking Medicine News(10 mins):Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 2Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 3Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 3Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 3
...nal of Sexual Medicine examines differences in sex...m, in pre- and post-menopausal women . Participant...ed concerns regarding their own feelings of sexual...els of desire to be normal. An assessment tool wa...
...ty in the UK have discovered mutations in the DNA ...n triggering breast cancer in women . The discove...ger women at higher-than-average risk of breast ca...with mammography before they reach 50 - the age wh...
...ey see, monkey do.' Researchers at Ohio Universit...ty to see red, they began to develop red and orang...eys, such as macaques and leaf monkeys, all have t...se primates to distinguish between blue, green and...
...y quit are more likely to try kicking the habit an...t the University of Rochester . Rochester researc...edicine at the University of Rochester School of M...ew findings at a Toronto conference this month tha...
Other Medicine News:Health News:Pre- and Post-menopausal Women Responses Equally to Most Sexual Desire Cues 2Health News:UK Scientists Identify Gene Mutations That Trigger Breast Cancer 2Health News:UK Scientists Identify Gene Mutations That Trigger Breast Cancer 3Health News:Color Vision Drove Primates to Develop Red Skin and Hair, Study Finds 2Health News:Choice is a Key Element in Success for Smokers Who Want to Quit 2
(Date:7/23/2008)...y 23 /PRNewswire-USNewswire/ -- The following was,...rman Conyers, Ranking Member Smith, and Members of...estify today., Since I appeared before this Commi...ter acquainted with the talented and dedicated pro...work they do, and I have come to,appreciate that m...
(Date:7/23/2008)...3 /- Dendreon Corporation,(...e Independent Data,Monitoring Committee (IDMC) to ...rall survival relating to the Company,s Phase 3 IM...eatment, also known as D9902B) clinical trial,of P...,s investigational,active cellular immunotherapy f...
(Date:7/22/2008)...ly 22 /- Nonin Medical, a leading inn...ore than 20 years, has entered,the clinical testin...e,regional oxygen saturation. Today,s most common ...monitoring of the regional blood oxygenation,in th... and outcomes from an ongoing clinical study at th...
(Date:7/22/2008)... PET Study Confirms Tyrima Exhibits Excellent Drug... - Results Support Initiation of Phase II Clini...22 /- CeNeRx BioPharma,Inc., a clini...nnovative,treatments for diseases of the central n...s lead candidate Tyrima(TM) into Phase II trials f...
Breaking Medicine Technology:Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Study examines cold medication use in young children 20744 1Study examines cold medication use in young children 20744 2Living fossils have long and short term memory 3492 1Mutual Protection Trust Earns Third A+ Rating From A M Best 20741 1Mutual Protection Trust Earns Third A+ Rating From A M Best 20741 2U S News Ranks Cincinnati Childrens Among Top Three U S Childrens Hospitals 20738 1U S News Ranks Cincinnati Childrens Among Top Three U S Childrens Hospitals 20738 2U S News Ranks Cincinnati Childrens Among Top Three U S Childrens Hospitals 20738 3
...al of SNS-595 in Acute,Leukemia Demonstrates Addit...f., June 11, 2007,/PRNewswire-FirstCall/ -- Sunesi...om clinical studies of two of the company,s,anti-c...the 12th,Congress of the European Hematology Assoc... from Sunesis, Phase 1 Study of SNS-595 in Acute,L...
...un 11, 2007 - Geron,Corporation (Nasdaq:GERN) toda...ndicating that GRNOPC1, the company,s human,embryo...atment of,spinal cord injury, evades a direct atta... scientist Ross Okamura at the Federation of,Clini... findings,could mean that patients treated with GR...
Other Medicine Technology:Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 2Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 3Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 4Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 5Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 6Research Indicates Geron's Human Embryonic Stem Cell-Based,Therapeutic for Spinal Cord Injury Evades Direct Attack by the,Human Immune System 2Research Indicates Geron's Human Embryonic Stem Cell-Based,Therapeutic for Spinal Cord Injury Evades Direct Attack by the,Human Immune System 3
These objectives have more contrast than the DLL objectives for enhanced contrast with tissue culture specimens. These objectives are designed for use on inverted microscopes and therefore their mark
...microscope technology that offers you much more th...s category. You will be impressed by the outstandi...n designed to make lab work as easy and safe as po...kflow. Your advantage: more time for the observati...
... advanced inverted microscope for automated live c...tion CFI60 optics, and extendible infinity design ...on, its super-nanoprecision z-axis motorized focus...for precise imaging in 3D. It's the first inverte...
... an innovative and efficient inverted routine micr...earch facility. , ,Outstanding Optical Performanc...ll magnifications. Objectives deliver superb optic...chromatic aberration free correction (CF), and top...
Medicine Products: